{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:49:07Z","timestamp":1760622547619},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1007\/s00408-005-2586-8","type":"journal-article","created":{"date-parts":[[2006,9,27]],"date-time":"2006-09-27T19:07:22Z","timestamp":1159384042000},"page":"217-222","source":"Crossref","is-referenced-by-count":19,"title":["Inhaled Fluticasone and Salmeterol Suppress Eosinophilic Airway Inflammation in Chronic Obstructive Pulmonary Disease: Relations with Lung Function and Bronchodilator Reversibility"],"prefix":"10.1007","volume":"184","author":[{"given":"Diahn-Warng","family":"Perng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Che","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang-Cheng","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reury-Perng","family":"Perng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Wei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"2586_CR1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1164\/ajrccm\/136.1.225","volume":"136","author":"American Thoracic Society","year":"1987","unstructured":"American Thoracic Society (1987) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136:225\u2013244","journal-title":"Am Rev Respir Dis"},{"key":"2586_CR2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1164\/arrd.1986.133.1.14","volume":"133","author":"NR Anthonisen","year":"1986","unstructured":"Anthonisen NR, Wright EC, Hodgkin JE (1986) Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 133:14\u201320","journal-title":"Am Rev Respir Dis"},{"key":"2586_CR3","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0149-2918(00)80089-2","volume":"22","author":"JT Barr","year":"2000","unstructured":"Barr JT, Schumacher GE, Freeman S, et al. (2000) American translation, modification, and validation of the St. George\u2019s Respiratory Questionnaire. Clin Ther 22:1121\u20131145","journal-title":"Clin Ther"},{"key":"2586_CR4","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(00)02872-5","volume":"356","author":"CE Brightling","year":"2000","unstructured":"Brightling CE, Monteiro W, Ward R, et al. (2000) Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 356:1480\u20131485","journal-title":"Lancet"},{"key":"2586_CR5","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/bmj.320.7245.1297","volume":"320","author":"PS Burge","year":"2000","unstructured":"Burge PS, Calverley PM, Jones PW, et al. (2000) Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 320:1297\u20131303","journal-title":"BMJ"},{"key":"2586_CR6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/thorax.58.8.659","volume":"58","author":"PM Calverley","year":"2003","unstructured":"Calverley PM, Burge PS, Spencer S, Anderson JA, Jones PW (2003) Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 58:659\u2013664","journal-title":"Thorax"},{"key":"2586_CR7","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1164\/ajrccm.160.5.9811058","volume":"160","author":"SV Culpitt","year":"1999","unstructured":"Culpitt SV, Maziak W, Loukidis S, et al. (1999) Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160:1635\u20131639","journal-title":"Am J Respir Crit Care Med"},{"key":"2586_CR8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1164\/ajrccm\/138.2.317","volume":"138","author":"RE Dales","year":"1988","unstructured":"Dales RE, Spitzer WO, Tousignant P, Schechter M, Suissa S (1988) Clinical interpretation of airway response to a bronchodilator. Epidemiologic considerations. Am Rev Respir Dis 138:317\u2013320","journal-title":"Am Rev Respir Dis"},{"key":"2586_CR9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1164\/ajrccm\/145.3.669","volume":"145","author":"R Djukanovic","year":"1992","unstructured":"Djukanovic R, Wilson JW, Britten KM, et al. (1992) Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 145:669\u2013674","journal-title":"Am Rev Respir Dis"},{"key":"2586_CR10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1378\/chest.115.3.697","volume":"115","author":"K Fujimoto","year":"1999","unstructured":"Fujimoto K, Kubo K, Yamamoto H, Yamaguchi S, Matsuzawa Y (1999) Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema. Chest 115:697\u2013702","journal-title":"Chest"},{"key":"2586_CR11","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/thorax.57.9.799","volume":"57","author":"MJ Gizycki","year":"2002","unstructured":"Gizycki MJ, Hattotuwa KL, Barnes N, Jeffery PK (2002) Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue. Thorax 57:799\u2013803","journal-title":"Thorax"},{"key":"2586_CR12","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1164\/rccm.2105025","volume":"165","author":"KL Hattotuwa","year":"2002","unstructured":"Hattotuwa KL, Gizycki MJ, Ansari TW, Jeffery PK, Barnes NC (2002) The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study. Am J Respir Crit Care Med 165:1592\u20131596","journal-title":"Am J Respir Crit Care Med"},{"key":"2586_CR13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1164\/ajrccm.155.2.9032192","volume":"155","author":"VM Keatings","year":"1997","unstructured":"Keatings VM, Jatakanon A, Worsdell YM, Barnes PJ (1997) Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 155:542\u2013548","journal-title":"Am J Respir Crit Care Med"},{"key":"2586_CR14","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199211123272003","volume":"327","author":"HA Kerstjens","year":"1992","unstructured":"Kerstjens HA, Brand PL, Hughes MD, et al. (1992) A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group. N Engl J Med 327:1413\u20131419","journal-title":"N Engl J Med"},{"key":"2586_CR15","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1056\/NEJM200012283432601","volume":"343","author":"LungHealth Study Research Group","year":"2000","unstructured":"Lung Health Study Research Group, (2000) Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 343:1902\u20131909","journal-title":"N Engl J Med"},{"key":"2586_CR16","first-page":"Global","volume":"Disease","author":"National","year":"2003","unstructured":"National Institutes of Health (2003) National Heart Lung, and Blood Institute. Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI\/WHO workshop report. Updated July 2003","journal-title":"Global Initiative for Chronic Obstructive Lung"},{"key":"2586_CR17","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1164\/ajrccm.162.5.9910112","volume":"162","author":"A Papi","year":"2000","unstructured":"Papi A, Romagnoli M, Baraldo S, et al. (2000) Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am J Respir Grit Care Med 162:1773\u20131777","journal-title":"Am J Respir Grit Care Med"},{"key":"2586_CR18","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1056\/NEJM199906243402503","volume":"340","author":"RA Pauwels","year":"1999","unstructured":"Pauwels RA, Lofdahl CG, Laitinen LA, et al. (1999) Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med 340:1948\u20131953","journal-title":"N Engl J Med"},{"key":"2586_CR19","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1378\/chest.125.5.1693","volume":"125","author":"DW Perng","year":"2004","unstructured":"Perng DW, Huang HY, Lee YC, Perng RP (2004) Leukotriene modifier vs inhaled corticosteroid in mild-to-moderate asthma: clinical and anti-inflammatory effects. Chest 125:1693\u20131699","journal-title":"Chest"},{"key":"2586_CR20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1378\/chest.126.2.375","volume":"126","author":"DW Perng","year":"2004","unstructured":"Perng DW, Huang HY, Chen HM, Lee YC, Perng RP (2004) Characteristics of airway inflammation and bronchodilator reversibility in COPD: a potential guide to treatment. Chest 126:375\u2013381","journal-title":"Chest"},{"key":"2586_CR21","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1183\/09031936.93.06091249","volume":"6","author":"I Pin","year":"1993","unstructured":"Pin I, Radford S, Kolendowicz R, et al. (1993) Airway inflammation in symptomatic and asymptomatic children with methacholine hyperresponsiveness. Eur Respir J 6:1249\u20131256","journal-title":"Eur Respir J"},{"key":"2586_CR22","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1164\/ajrccm.158.5.9804028","volume":"158","author":"E Pizzichini","year":"1998","unstructured":"Pizzichini E, Pizzichini M, Gibson P, et al. (1998) Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med 158:1511\u20131517","journal-title":"Am J Respir Crit Care Med"},{"key":"2586_CR23","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/thorax.58.11.937","volume":"58","author":"ER Sutherland","year":"2003","unstructured":"Sutherland ER, Allmers H, Ayas NT, Venn AJ, Martin RJ (2003) Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis. Thorax 58:937\u2013941","journal-title":"Thorax"},{"key":"2586_CR24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1183\/09031936.03.00031402","volume":"21","author":"W Szafranski","year":"2003","unstructured":"Szafranski W, Cukier A, Ramirez A, et al. (2003) Efficacy and safety of budesonide\/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J 21:74\u201381","journal-title":"Eur Respir J"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-005-2586-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-005-2586-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-005-2586-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:25:10Z","timestamp":1683591910000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-005-2586-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["2586"],"URL":"https:\/\/doi.org\/10.1007\/s00408-005-2586-8","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}